Improved potency of pyridin-2(1H)one derivatives for the treatment of mechanical allodynia - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue European Journal of Medicinal Chemistry Année : 2021

Improved potency of pyridin-2(1H)one derivatives for the treatment of mechanical allodynia

Alexia Visseq
  • Fonction : Auteur
Amélie Descheemaeker
  • Fonction : Auteur
Karine Hérault
  • Fonction : Auteur
Francis Giraud
Isabelle Abrunhosa-Thomas
Alain Artola
  • Fonction : Auteur
  • PersonId : 1109268
Fabrice Anizon
  • Fonction : Auteur
  • PersonId : 1109269
Radhouane Dallel
Pascale Moreau
  • Fonction : Auteur

Résumé

Mechanical allodynia, a painful sensation caused by innocuous touch, is a major chronic pain symptom, which often remains without an effective treatment. There is thus a need for new anti-allodynic treatments based on new drug classes. We recently synthetized new 3,5-disubstituted pyridin-2(1H)-one derivatives. By substituting the pyridinone at the 3-position by various aryl/heteroaryl moieties and at the 5-position by a phenylamino group, we discovered that some derivatives exhibited a strong antiallodynic potency in rats. Here, we report that varying the substitution of the pyridinone 5-position, the 3-position being substituted by an indol-4-yl moiety, further improves such anti-allodynic potency. Compared with 2, one of the two most active compounds of the first series, eleven out of nineteen newly synthetized compounds showed higher anti-allodynic potency, with two of them completely preventing mechanical allodynia. In the first series, hit compounds 1 and 2 appeared to be inhibitors of p38a MAPK, a protein kinase known to underlie pain hypersensitivity in animal models. Depending on the substitution at the 5-position, some newly synthetized compounds were also stronger p38a MAPK inhibitors. Surprisingly, though, anti-allodynic effects and p38a MAPK inhibitory potencies were not correlated, suggesting that other biological target(s) is/are involved in the analgesic activity in this series. Altogether, these results confirm that 3,5-disubstituted pyridine-2(1H)-one derivatives are of high interest for the development of new treatment of mechanical allodynia.

Dates et versions

hal-04487387 , version 1 (04-03-2024)

Identifiants

Citer

Alexia Visseq, Amélie Descheemaeker, Karine Hérault, Francis Giraud, Isabelle Abrunhosa-Thomas, et al.. Improved potency of pyridin-2(1H)one derivatives for the treatment of mechanical allodynia. European Journal of Medicinal Chemistry, 2021, 225, ⟨10.1016/j.ejmech.2021.113748⟩. ⟨hal-04487387⟩

Collections

PRES_CLERMONT ND
2 Consultations
2 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More